Yisheko Biotech invested 10.6 million euros to establish a free economic zone in LithuaniaThe New Manufacturing Center (EMT) has been establishedofficially launchedAs a strategic manufacturing center in Europe, the new factory covers an area of 7900 square meters, integrating medical research and development teams and product management, improving overall production capacity, and accelerating research and development innovation.

The EMT factory adopts automation and new engineering design to achieve efficient production processes. At the same time, there are exhibition halls, conference rooms, and seminar offices inside to meet diverse usage needs. In the future, the factory will also hold training and seminars for service engineers, distributors, and potential customers.

Our EMT factory has now become an important manufacturing service center within the European Union, which strengthens our market share. The factory is advancing the Esco 3.0 era by supporting research and development, optimizing production, and establishing training centers for service engineers and cooperative distributors, which also reflects our commitment to customers and employees. ”Mr. Lin Xiangqian, CEO of Yishike Biotechnology, stated that,We are pleased to see this new move advancing the mission of Yishike Biotechnology to enhance our influence in the European Union and globally